Author:
Heselmeyer-Haddad Kerstin,Berroa Garcia Lissa Y.,Bradley Amanda,Ortiz-Melendez Clarymar,Lee Woei-Jyh,Christensen Rebecca,Prindiville Sheila A.,Calzone Kathleen A.,Soballe Peter W.,Hu Yue,Chowdhury Salim A.,Schwartz Russell,Schäffer Alejandro A.,Ried Thomas
Funder
National Institutes of Health
U.S. National Library of Medicine
National Cancer Institute
Subject
Pathology and Forensic Medicine
Reference63 articles.
1. Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer: results from the GeparQuattro study (GBG 40);von Minckwitz;Breast Cancer Res Treat,2012
2. Preinvasive breast cancer;Sgroi;Annu Rev Pathol,2010
3. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes;Virnig;J Natl Cancer Inst,2010
4. Global cancer statistics;Jemal;CA Cancer J Clin,2011
5. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD. Available at http://seer.cancer.gov/csr/1975_2009_pops09, based on November 2011 SEER data submission, posted online April 2012
Cited by
100 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献